Skip to main content
MapleLMS Implementation
Conferences and Meetings 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

Short name: 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II
Course start date: 11/05/2025

Sections

General
0 activities

Combating "Referral Madness Syndrome"in Classical Hematology
Cost-Effectiveness of Eltrombopag Plus Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone in Adults with Severe Aplastic Anemia in the United States
From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation
Impact of Rapid Latex Immunoassay (LIA) Implementation on Management of Heparin Induced Thrombocytopenia (HIT): A Retrospective Single Institution Study
Implementation of Automated Thrombosis and Bleeding Risk Assessment in Cancer Patients Undergoing Systemic Therapy
International Clinical Consensus on Leukocyte Adhesion Deficiency-I: A Modified Delphi Analysis
Management of Iron Deficiency Anemia in Women of Reproductive Age Using a Telemedicine Platform Fails to Adequately Address Heavy Menstrual Bleeding, Resulting in High Recurrence Rates
Patient Decision Aid for Extended Duration Thromboprophylaxis for Major Abdominopelvic Cancer Surgery: A Usability Study
Patient-Centered Management of Heavy Menstrual Bleeding on Anticoagulants: An International Survey
Standardized Approach to Peri-Operative and Peri-Procedural Chemical Venous-Thromboembolism Prophylaxis
The EPP LIGHT Study: A Survey Describing the Burden of Erythropoietic Protoporphyria and X-Linked Protoporphyria
Uncovering Root Causes Underlying Gaps in the Evaluation and Integration of the Latest Clinical Evidence in Congenital Thrombotic Thrombocytopenic Purpura: Key Findings from a National Hematology Care Team Survey
“I Didn’t Know I Had a Choice” – Patient Values and Preferences Regarding Resumption of Oral Anticoagulants after Gastrointestinal Bleeding